Nicoya Lifesciences is a biotechnology company that specializes in providing advanced analytical instruments, particularly in the field of Surface Plasmon Resonance (SPR). Founded in 2012, the company aims to make cutting-edge technology accessible to researchers by reducing the cost and complexity of scientific instruments. Their key products include the Open SPR and Alto systems, which are designed to deliver real-time binding kinetics and affinity data with minimal sample requirements. With over 600 researchers using their systems worldwide, Nicoya has established a strong market position and is trusted by more than 500 research labs across 40 countries, making significant contributions to the fields of drug discovery and biomolecular research.
Something looks off?